{
    "2020-09-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis Issues Update On AVXS-101 Intrathecal Clinical Development Program",
                "features": {
                    "keywords": [
                        "Novartis",
                        "AVXS-101",
                        "Intrathecal",
                        "Clinical",
                        "Development",
                        "Program"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program",
                "features": {
                    "keywords": [
                        "Novartis",
                        "AVXS-101",
                        "Intrathecal",
                        "Clinical",
                        "Development",
                        "Program"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}